Peptides as a Drug: Purity Specifications, GMP Certification, and Manufacturing Sourcing Guide
Peptides as a Drug: Purity Specifications, GMP Certification, and Manufacturing Sourcing Guide For pharmaceutical-grade peptides, purity specifications are non-negotiable; clinical efficacy demands ≥98% purity verified by HPLC and mass spectrometry. GMP certification ensures sterile, endotoxin-free production, critical for therapeutic safety. When sourcing, compare manufacturing origins: US/EU facilities typically offer stricter regulatory compliance than unregulated markets. Product parameters like peptide sequence accuracy and salt content directly impact stability. Brand analysis reveals that certified manufacturers dominate the market trend toward high-purity research peptides. Logistics require cold-chain shipping with temperature logs to prevent degradation. For therapeutic use, always verify Certificate of Analysis (CoA) and third-party testing. Selecting peptides with documented purity data reduces contamination risks in drug development.